Stock SMSLIFE SMS LIFESCIENCES INDIA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials SMS Lifesciences India Limited

Equities

SMSLIFE

INE320X01016

Pharmaceuticals

End-of-day quote NSE India S.E.
Other stock markets
 03:30:00 14/06/2024 am IST 		5-day change 1st Jan Change
801.8 INR -0.34% Intraday chart for SMS Lifesciences India Limited +6.03% +51.40%
27/05 SMS Lifesciences India Limited Recommends Final Dividend for the Year 2023-24 CI
27/05 SMS Lifesciences India Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 1,159 1,678 540.4 1,487 2,114 1,542
Enterprise Value (EV) 1 1,428 2,127 1,165 2,028 2,878 2,511
P/E ratio 17.8 x 9.4 x 5.31 x 11 x 8.35 x 13.5 x
Yield - 0.27% - 0.3% 0.21% 0.29%
Capitalization / Revenue 0.54 x 0.44 x 0.21 x 0.56 x 0.6 x 0.49 x
EV / Revenue 0.67 x 0.56 x 0.45 x 0.76 x 0.82 x 0.8 x
EV / EBITDA 10.8 x 6.11 x 4.67 x 6.82 x 8.5 x 8.91 x
EV / FCF 32.6 x -173 x -6.75 x 127 x -5.04 x -6 x
FCF Yield 3.07% -0.58% -14.8% 0.78% -19.9% -16.7%
Price to Book 1.31 x 1.58 x 0.47 x 1.15 x 1.39 x 0.91 x
Nbr of stocks (in thousands) 3,023 3,023 3,023 3,023 3,023 3,023
Reference price 2 383.2 555.0 178.8 491.8 699.2 510.0
Announcement Date 24/09/18 06/09/19 08/09/20 08/09/21 08/09/22 07/09/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 2,130 3,779 2,608 2,656 3,497 3,156
EBITDA 1 132.6 348.4 249.3 297.4 338.5 282
EBIT 1 75.61 284.7 175.8 223.9 243.3 180.5
Operating Margin 3.55% 7.53% 6.74% 8.43% 6.96% 5.72%
Earnings before Tax (EBT) 1 63.97 253.8 146.7 195.7 327.3 165.9
Net income 1 65.01 178.5 101.8 135.6 253.2 114.6
Net margin 3.05% 4.72% 3.9% 5.1% 7.24% 3.63%
EPS 2 21.50 59.03 33.68 44.84 83.76 37.92
Free Cash Flow 1 43.85 -12.27 -172.4 15.91 -571.5 -418.7
FCF margin 2.06% -0.32% -6.61% 0.6% -16.34% -13.27%
FCF Conversion (EBITDA) 33.06% - - 5.35% - -
FCF Conversion (Net income) 67.45% - - 11.74% - -
Dividend per Share - 1.500 - 1.500 1.500 1.500
Announcement Date 24/09/18 06/09/19 08/09/20 08/09/21 08/09/22 07/09/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 269 449 624 541 764 969
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.03 x 1.289 x 2.504 x 1.818 x 2.257 x 3.436 x
Free Cash Flow 1 43.8 -12.3 -172 15.9 -571 -419
ROE (net income / shareholders' equity) 7.64% 18.3% 9.17% 11.1% 17.2% 6.44%
ROA (Net income/ Total Assets) 2.69% 7.97% 4.2% 5.04% 4.61% 3%
Assets 1 2,421 2,240 2,422 2,690 5,488 3,819
Book Value Per Share 2 292.0 352.0 383.0 427.0 504.0 558.0
Cash Flow per Share 2 1.440 7.190 7.100 28.20 3.260 4.230
Capex 1 35 244 234 356 512 486
Capex / Sales 1.64% 6.46% 8.96% 13.39% 14.63% 15.39%
Announcement Date 24/09/18 06/09/19 08/09/20 08/09/21 08/09/22 07/09/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
SMS LIFESCIENCES INDIA LIMITED Stock SMS Lifesciences India Limited
+51.40% 29.02M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+50.70% 791B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+41.96% 630B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.15% 350B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.77% 328B
ABBVIE INC. Stock AbbVie Inc.
+8.79% 298B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.02% 246B
ROCHE HOLDING AG Stock Roche Holding AG
+1.27% 225B
NOVARTIS AG Stock Novartis AG
+11.95% 218B
AMGEN INC. Stock Amgen Inc.
+3.68% 160B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SMSLIFE Stock
  4. Financials SMS Lifesciences India Limited